Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	AZD0914/ETX0914 2000mg	72
Overall Study	STARTED	AZD0914/ETX0914 3000mg	67
Overall Study	STARTED	Ceftriaxone 500mg	41
Overall Study	Test of Cure Visit	AZD0914/ETX0914 2000mg	72
Overall Study	Test of Cure Visit	AZD0914/ETX0914 3000mg	67
Overall Study	Test of Cure Visit	Ceftriaxone 500mg	40
Overall Study	COMPLETED	AZD0914/ETX0914 2000mg	68
Overall Study	COMPLETED	AZD0914/ETX0914 3000mg	66
Overall Study	COMPLETED	Ceftriaxone 500mg	39
Overall Study	NOT COMPLETED	AZD0914/ETX0914 2000mg	4
Overall Study	NOT COMPLETED	AZD0914/ETX0914 3000mg	1
Overall Study	NOT COMPLETED	Ceftriaxone 500mg	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02257918/flow